Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double‐blind placebo‐controlled study in Japan

Sekiguchi, Kenji; Kohara, Nobuo; Baba, Masayuki; Komori, Tetsuo; Naito, Yutaka; Imai, Tomihiro; Satoh, Jo; Yamaguchi, Yasuyuki; Hamatani, Tatsuto; Ranirestat Group, the

doi:10.1111/jdi.12890

Public

Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: A randomized double‐blind placebo‐controlled study in Japan

Published in Journal of Diabetes Investigation • Jul 5, 2018

Authors:

Kenji Sekiguchi

Nobuo Kohara

Masayuki Baba

Abstract

AIMS/INTRODUCTION: Diabetic polyneuropathy is one of the most frequent diabetic complications, and impairs patients' quality of life. We evaluated the efficacy and safety of ranirestat (40 mg/day) in patients with diabetic polyneuropathy. MATERIALS AND METHODS: This was a multicenter, placebo-contro...

Subject

Medicine

Nerve conduction velocity

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!